207 related articles for article (PubMed ID: 18577524)
1. Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
J Biol Chem; 2008 Aug; 283(35):23811-8. PubMed ID: 18577524
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
3. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
[TBL] [Abstract][Full Text] [Related]
5. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
[TBL] [Abstract][Full Text] [Related]
6. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in relaxin-3-related research.
Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW
Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
[TBL] [Abstract][Full Text] [Related]
8. Structural properties of relaxin chimeras.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
[TBL] [Abstract][Full Text] [Related]
9. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
10. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors.
Hossain MA; Rosengren KJ; Haugaard-Jönsson LM; Zhang S; Layfield S; Ferraro T; Daly NL; Tregear GW; Wade JD; Bathgate RA
J Biol Chem; 2008 Jun; 283(25):17287-97. PubMed ID: 18434306
[TBL] [Abstract][Full Text] [Related]
11. INSL5 is a high affinity specific agonist for GPCR142 (GPR100).
Liu C; Kuei C; Sutton S; Chen J; Bonaventure P; Wu J; Nepomuceno D; Kamme F; Tran DT; Zhu J; Wilkinson T; Bathgate R; Eriste E; Sillard R; Lovenberg TW
J Biol Chem; 2005 Jan; 280(1):292-300. PubMed ID: 15525639
[TBL] [Abstract][Full Text] [Related]
12. Identification of relaxin-3/INSL7 as a ligand for GPCR142.
Liu C; Chen J; Sutton S; Roland B; Kuei C; Farmer N; Sillard R; Lovenberg TW
J Biol Chem; 2003 Dec; 278(50):50765-70. PubMed ID: 14522967
[TBL] [Abstract][Full Text] [Related]
13. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
14. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
15. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.
Sutton SW; Bonaventure P; Kuei C; Roland B; Chen J; Nepomuceno D; Lovenberg TW; Liu C
Neuroendocrinology; 2004; 80(5):298-307. PubMed ID: 15677880
[TBL] [Abstract][Full Text] [Related]
16. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
17. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
18. The evolution of the relaxin peptide family and their receptors.
Wilkinson TN; Bathgate RA
Adv Exp Med Biol; 2007; 612():1-13. PubMed ID: 18161477
[TBL] [Abstract][Full Text] [Related]
19. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
20. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
